Zevra Therapeutics, Inc.
ZVRA
Revenue
0.00
0.000.00%
3 Months ChangeAssets
144.41M
▼-6.88M▼-4.54%
3 Months ChangeLiabilities
111.93M
▲9.47M▲9.24%
3 Months ChangeFree Cash Flow
-16.17M
▼-12.09M▼-296.78%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-09-20
Form 8-K
ID: 0001437749-24-029747
2024-08-14
Form 10-Q
ID: 0001437749-24-026474
2024-08-13
Form 8-K
ID: 0001437749-24-026397
2024-08-09
Form 8-K
ID: 0001193125-24-197943
2024-08-08
Form 8-K
ID: 0001193125-24-196961
2024-08-05
Form 8-K
ID: 0001437749-24-024543
2024-07-12
Form 8-K
ID: 0001437749-24-022668
2024-07-09
Form 8-K
ID: 0001437749-24-022362
2024-06-03
Form 8-K
ID: 0001437749-24-019074
2024-05-13
Form 8-K
ID: 0001437749-24-016275